Lanceljx
04-22

Short answer: $380 is a real battleground, but it is not a “clean” support going into this print. The risk is skewed to a post-earnings break or sharp whipsaw, not a stable hold.


Here is how the setup looks:


1) Technical + positioning


Price is sitting near recent consolidation lows (~$386).


Into earnings, liquidity thins and supports weaken because positioning is hedged, not directional.


If results or guidance disappoint, $380 can break quickly due to stop clusters.



2) Fundamentals are fragile beneath the surface


Expected EPS ~0.33–0.36 and revenue ~US$21–22B, but delivery miss + cash burn concerns are rising 


Market focus has shifted from autos to AI / robotaxi execution, where progress is still “slower than expected” 



3) Your two risks are very real catalysts


FSD legal overhang: long-running claims that autonomy was overstated continue to resurface, keeping liability risk alive 


Tax structuring scrutiny: reports of ~$18B profit shifting and hundreds of millions in tax savings add policy risk and headline volatility 



4) What actually decides $380


If earnings = “good but not convincing” → likely break then reclaim (fake downside)


If margins + FSD narrative disappoint → clean breakdown toward next range (~350–360)


If strong FSD monetisation + margin resilience → short squeeze above 400



Bottom line

$380 is weak support into an event, not strong support. The market is pricing uncertainty, not stability. The real move comes after guidance, not before.

TSLA Cybercab Mass Production Launches: Can It Justify Premium?
Tesla fell 3.56% on Thursday, continuing its post earnings drop. Cybercab trial production officially commenced, while analyst Gary Black warned that tightening autonomous driving regulations could compress valuations — the 'Self-Driving Roll Back' narrative is eroding the growth premium. Shares broke below the key $380 level, shifting near-term support to $370. Can Cybercab convert to scaled delivery within the production window, and when will the FSD regulatory environment stabilize — two critical variables for rebuilding the current valuation floor?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
1